Alopecia Areata for Alopecia Areata

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Alopecia Areata+2 MoreLumiton yarn sleeve - Other
Eligibility
18 - 65
All Sexes
What conditions do you have?
Select

Study Summary

This trial is looking at whether or not a new, more accessible phototherapy treatment is effective for psoriasis.

Eligible Conditions
  • Alopecia Areata
  • Polymorphous Light Eruption
  • Psoriasis

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

3 Primary · 0 Secondary · Reporting Duration: Week 12

Week 12
Disease severity - PASI
Disease severity - SALT
Disease severity - photo

Trial Safety

Safety Progress

1 of 3

Trial Design

3 Treatment Groups

Alopecia Areata
1 of 3
Polymorphous Light Eruption
1 of 3
Psoriasis
1 of 3

Active Control

15 Total Participants · 3 Treatment Groups

Primary Treatment: Alopecia Areata · No Placebo Group · N/A

Alopecia Areata
Other
ActiveComparator Group · 1 Intervention: Lumiton yarn hat · Intervention Types: Other
Polymorphous Light Eruption
Other
ActiveComparator Group · 1 Intervention: Lumiton yarn shirt · Intervention Types: Other
Psoriasis
Other
ActiveComparator Group · 1 Intervention: Lumiton yarn sleeve · Intervention Types: Other

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: week 12

Who is running the clinical trial?

Wake Forest University Health SciencesLead Sponsor
1,127 Previous Clinical Trials
1,137,412 Total Patients Enrolled
5 Trials studying Alopecia Areata
296 Patients Enrolled for Alopecia Areata
Joseph Jorizzo, M.D.Principal InvestigatorWake Forest University Health Sciences

Eligibility Criteria

Age 18 - 65 · All Participants · 4 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
References